16:00-16:30

Gathering and coffee

16:30-16:35

Opening words

Prof. Meital Zilberman, President of the ISMBE, Department of Biomedical Engineering, Tel Aviv university

Asst. Prof. Daphne Weihs, Head of the ISMBE Scientific Committee, Faculty of Biomedical Engineering, Technion-IIT

16:35-17:00

Prof. Dan Peer, Chair, Cancer Biology Research Center, Faculty of Life Science, Tel Aviv University

From Glioma and ovarian cancer to hematological malignancies: novel approaches for therapeutic gene silencing using tagged nanomedicines

17:00-17:25

Asst. Prof. Daphne Weihs, Faculty of Biomedical Engineering, Technion-Israel Institute of Technology

Cancer mechanobiology: how forceful interactions of tumor cells can predict the likelihood for metastasis 

17:25-17:50

Dr. Yael Mardor, Chief Scientist, The Advanced Technology Center, Sheba Medical Center and Faculty of Medicine, Tel Aviv University

MRI-based treatment response assessment maps (TRAMs) for high resolution differentiation between tumor and treatment effects in patients with brain tumors

17:50-18:15

Dr. Ido Wolf, Head, Medical oncology, Oncology Division, Tel Aviv Sourasky Medical Center

Do we still need chemotherapy in 2017?

18:20-18:45

Open discussion panel with the speakers